Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils.
about
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.Pertussis toxin and adenylate cyclase toxin provide a one-two punch for establishment of Bordetella pertussis infection of the respiratory tractPertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology toolsCytoskeleton as an emerging target of anthrax toxinsUse of a Toxin Neutralization Assay To Characterize the Serologic Response to Adenylate Cyclase Toxin after Infection with Bordetella pertussisReview of the neutrophil response to Bordetella pertussis infection.The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies.Bordetella adenylate cyclase toxin is a unique ligand of the integrin complement receptor 3Adenylate cyclase toxin (ACT) from Bordetella hinzii: characterization and differences from ACT of Bordetella pertussisRole of neutrophils in response to Bordetella pertussis infection in mice.Macrophage cytotoxicity produced by adenylate cyclase toxin from Bordetella pertussis: more than just making cyclic AMP!Immunoglobulin A-mediated protection against Bordetella pertussis infection.Monoclonal antibodies against Vibrio vulnificus RtxA1 elicit protective immunity through distinct mechanisms.Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activityPertussis: persistent pathogen, imperfect vaccines.Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.Is there a need for a new generation of vaccines against pertussis?Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activitiesToxins from bacteria.Pertussis: a matter of immune modulation.Importance of (antibody-dependent) complement-mediated serum killing in protection against Bordetella pertussis.Interaction with adenylate cyclase toxin from Bordetella pertussis affects the metal binding properties of calmodulin.Influence of CR3 (CD11b/CD18) expression on phagocytosis of Bordetella pertussis by human neutrophilsCharacterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults.Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes.Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction.Structure-Function Relationships Underlying the Capacity of Bordetella Adenylate Cyclase Toxin to Disarm Host Phagocytes.Site I Inactivation Impacts Calmodulin Calcium Binding and Activation of Bordetella pertussis Adenylate Cyclase Toxin.Revealing how an adenylate cyclase toxin uses bait and switch tactics in its activation.cAMP signalling of Bordetella adenylate cyclase toxin through the SHP-1 phosphatase activates the BimEL-Bax pro-apoptotic cascade in phagocytes.Detection of opsonizing antibodies directed against a recently circulating Bordetella pertussis strain in paired plasma samples from symptomatic and recovered pertussis patients
P2860
Q24522458-71EB83AD-EFFA-4B10-A605-E163EBA4721CQ24523604-4BDE3243-6724-4AF3-9531-D54E73CAE61DQ24602050-355F2EC5-6095-412A-8B39-9AB1A8DB4891Q27005620-44929EBE-95BF-450A-AC11-CB0A30A4E59FQ30275563-F9F61484-8709-4DBD-9DCE-09663A980BFDQ30278579-AF7081F3-C29E-4525-B5FB-441F33CA25A7Q30301113-8671C0AA-E818-4842-8C8C-E711C975BF34Q30360778-2C1F8824-03E0-40D8-8642-A1BFDF28BBBEQ30438593-6293EFAB-278D-4028-850C-5454AC4AC6C1Q30438786-5C4C3AC5-A960-4736-9242-6B7F8EC821ADQ30439119-E4E33720-14B0-49EA-BD25-5458B7107611Q34008531-28FE4109-531C-456B-9529-15678EA3877FQ34596138-25F0A65F-A7E2-4C82-89B4-F166201BB53AQ35138820-CD8CB9F1-6BC8-4118-A725-69BBE096CF62Q35193561-A431CCC8-B4B6-40BC-8DE6-CB7FF7C8CE82Q35220336-58190EDC-5543-4825-8A3F-799D6AA6438EQ35946858-39E6A138-499A-45C9-A8B7-EC7687A925B8Q36458388-2F626DB7-2092-4D34-A864-D135447DCC6FQ37623676-F99F4737-919B-443F-BEAA-4166C8B54A37Q37722655-E3E835F5-E79A-4273-AA9B-5C61107D7991Q37825920-8147DF42-00F3-405B-B58D-014FCD066209Q38235833-79DB85C6-644D-4D11-80B4-FA8853309CDCQ39015810-9A064572-AD00-40F7-AE61-72D6D272B4B1Q39392681-E7E714FC-32DC-45B9-9415-EEBBE7E73244Q39517579-83E1685F-32F7-4FCB-8B77-BABE0E25E886Q39522998-CAB1E51D-D2EF-4CFF-A68A-5F9FAEDC549BQ42047758-9FEA3ED1-1E1E-46A5-B6BC-13836DE84C1AQ44920994-45C8177D-4B16-44D0-9424-D50066EAC1F3Q47137462-E7F606A3-28E7-4F65-8804-01C1FAB395E0Q52683132-76F47117-8BAD-4A4A-968F-D0B4D05C5D5FQ55043889-43B364AC-E012-45A7-AE73-675383C2BD7BQ58786827-DA09AA92-FA92-4A2E-90F0-72CF49E8B3FB
P2860
Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Neutralizing antibodies to ade ...... ertussis by human neutrophils.
@ast
Neutralizing antibodies to ade ...... ertussis by human neutrophils.
@en
type
label
Neutralizing antibodies to ade ...... ertussis by human neutrophils.
@ast
Neutralizing antibodies to ade ...... ertussis by human neutrophils.
@en
prefLabel
Neutralizing antibodies to ade ...... ertussis by human neutrophils.
@ast
Neutralizing antibodies to ade ...... ertussis by human neutrophils.
@en
P2093
P2860
P921
P1476
Neutralizing antibodies to ade ...... ertussis by human neutrophils.
@en
P2093
C L Weingart
E L Hewlett
P S Mobberley-Schuman
P2860
P304
P356
10.1128/IAI.68.12.7152-7155.2000
P407
P577
2000-12-01T00:00:00Z